Atlas Trials

Lithium Drug-Drug Interaction Study With Lurasidone HCl

Clinical trial NCT01074073 · COMPLETED

Trial details

NCT number
NCT01074073
Sponsor
Sumitomo Pharma America, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2008-08-01
Primary completion
2008-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.